In the Green: Harmony Biosciences Holdings Inc (HRMY) Closes at 35.57, Up/Down -9.35 from Previous Day

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Harmony Biosciences Holdings Inc (NASDAQ: HRMY) closed at $35.57 down -9.35% from its previous closing price of $39.24. In other words, the price has decreased by -$9.35 from its previous closing price. On the day, 1.02 million shares were traded. HRMY stock price reached its highest trading level at $39.62 during the session, while it also had its lowest trading level at $35.2501.

Ratios:

For a deeper understanding of Harmony Biosciences Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.50. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.13. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.32.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on September 10, 2024, initiated with a Buy rating and assigned the stock a target price of $56.

On June 21, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $48.

BofA Securities Downgraded its Neutral to Underperform on January 02, 2024, while the target price for the stock was maintained at $30.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 01 ’24 when Dierks Jeffrey sold 400 shares for $40.19 per share. The transaction valued at 16,077 led to the insider holds 0 shares of the business.

JEFFREY G DIERKS bought 21,796 shares of HRMY for $871,840 on Oct 01 ’24. On Sep 30 ’24, another insider, Dierks Jeffrey, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 35,846 shares for $40.03 each. As a result, the insider received 1,434,951 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRMY now has a Market Capitalization of 2021610240 and an Enterprise Value of 1863763840. As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.21, and their Forward P/E ratio for the next fiscal year is 9.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.81. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.08 while its Price-to-Book (P/B) ratio in mrq is 3.75. Its current Enterprise Value per Revenue stands at 2.841 whereas that against EBITDA is 9.204.

Stock Price History:

Over the past 52 weeks, HRMY has reached a high of $40.60, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is -1.00%, while the 200-Day Moving Average is calculated to be 9.43%.

Shares Statistics:

For the past three months, HRMY has traded an average of 399.33K shares per day and 677780 over the past ten days. A total of 56.77M shares are outstanding, with a floating share count of 30.70M. Insiders hold about 45.98% of the company’s shares, while institutions hold 65.55% stake in the company. Shares short for HRMY as of 1726185600 were 8412386 with a Short Ratio of 21.07, compared to 1723680000 on 8726295. Therefore, it implies a Short% of Shares Outstanding of 8412386 and a Short% of Float of 66.080004.

Most Popular